Cargando…

Case report: The effective response to pembrolizumab in combination with bevacizumab in the treatment of a recurrent glioblastoma with multiple extracranial metastases

Multiple extracranial metastases of recurrent glioblastoma are rare and often indicate a very poor prognosis. The main conventional treatments are chemotherapy, radiotherapy, chemoradiotherapy or antiangiogenic therapy. Median overall survival is 2.3 to 6 months after the detection of extracranial m...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Gang, Fang, Yu, Zhou, Ming, Li, Wei, Dong, Dapeng, Chen, Jing, Da, Yong, Wang, Kunpeng, Li, Xinru, Zhang, Xiaoyan, Ma, Tonghui, Shen, Ge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424992/
https://www.ncbi.nlm.nih.gov/pubmed/36052225
http://dx.doi.org/10.3389/fonc.2022.948933